These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 22198753

  • 1. MicroRNAs and their roles in osteoclast differentiation.
    Xia Z, Chen C, Chen P, Xie H, Luo X.
    Front Med; 2011 Dec; 5(4):414-9. PubMed ID: 22198753
    [Abstract] [Full Text] [Related]

  • 2. The role of microRNAs in osteoclasts and osteoporosis.
    Tang P, Xiong Q, Ge W, Zhang L.
    RNA Biol; 2014 Dec; 11(11):1355-63. PubMed ID: 25692234
    [Abstract] [Full Text] [Related]

  • 3. Validation of downregulated microRNAs during osteoclast formation and osteoporosis progression.
    Ma Y, Shan Z, Ma J, Wang Q, Chu J, Xu P, Qin A, Fan S.
    Mol Med Rep; 2016 Mar; 13(3):2273-80. PubMed ID: 26783047
    [Abstract] [Full Text] [Related]

  • 4. Impaired micro-RNA pathways diminish osteoclast differentiation and function.
    Sugatani T, Hruska KA.
    J Biol Chem; 2009 Feb 13; 284(7):4667-78. PubMed ID: 19059913
    [Abstract] [Full Text] [Related]

  • 5. [A review on microRNAs regulation in osteoclast differentiation and function].
    Lian J, Du W, Meng S.
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Oct 13; 33(5):543-7. PubMed ID: 26688953
    [Abstract] [Full Text] [Related]

  • 6. Regulation of osteoclast function.
    Nakamura I, Takahashi N, Jimi E, Udagawa N, Suda T.
    Mod Rheumatol; 2012 Apr 13; 22(2):167-77. PubMed ID: 21953286
    [Abstract] [Full Text] [Related]

  • 7. MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for Osteoporosis.
    Ji X, Chen X, Yu X.
    Int J Mol Sci; 2016 Mar 09; 17(3):349. PubMed ID: 27005616
    [Abstract] [Full Text] [Related]

  • 8. Estrogen inhibits osteoclasts formation and bone resorption via microRNA-27a targeting PPARγ and APC.
    Guo L, Chen K, Yuan J, Huang P, Xu X, Li C, Qian N, Qi J, Shao Z, Deng L, He C, Xu J.
    J Cell Physiol; 2018 Jan 09; 234(1):581-594. PubMed ID: 30272823
    [Abstract] [Full Text] [Related]

  • 9. miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.
    Krzeszinski JY, Wei W, Huynh H, Jin Z, Wang X, Chang TC, Xie XJ, He L, Mangala LS, Lopez-Berestein G, Sood AK, Mendell JT, Wan Y.
    Nature; 2014 Aug 28; 512(7515):431-5. PubMed ID: 25043055
    [Abstract] [Full Text] [Related]

  • 10. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis.
    Zhao B, Takami M, Yamada A, Wang X, Koga T, Hu X, Tamura T, Ozato K, Choi Y, Ivashkiv LB, Takayanagi H, Kamijo R.
    Nat Med; 2009 Sep 28; 15(9):1066-71. PubMed ID: 19718038
    [Abstract] [Full Text] [Related]

  • 11. miRNAs in osteoclast biology.
    Weivoda MM, Lee SK, Monroe DG.
    Bone; 2021 Feb 28; 143():115757. PubMed ID: 33212320
    [Abstract] [Full Text] [Related]

  • 12. MicroRNAs as Potential Targets for Treatment of Osteoclast-Related Diseases.
    Li H, Zhai Z, Qu X, Xu J, Qin A, Dai K.
    Curr Drug Targets; 2018 Feb 28; 19(5):422-431. PubMed ID: 27138766
    [Abstract] [Full Text] [Related]

  • 13. Molecular and cellular basis of bone resorption.
    Gruber R.
    Wien Med Wochenschr; 2015 Feb 28; 165(3-4):48-53. PubMed ID: 25223736
    [Abstract] [Full Text] [Related]

  • 14. Differentiation and function of osteoclasts.
    Miyamoto T, Suda T.
    Keio J Med; 2003 Mar 28; 52(1):1-7. PubMed ID: 12713016
    [Abstract] [Full Text] [Related]

  • 15. A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapy.
    Cai M, Yang L, Zhang S, Liu J, Sun Y, Wang X.
    Int J Nanomedicine; 2017 Mar 28; 12():7469-7482. PubMed ID: 29075114
    [Abstract] [Full Text] [Related]

  • 16. SNX10 is required for osteoclast formation and resorption activity.
    Zhu CH, Morse LR, Battaglino RA.
    J Cell Biochem; 2012 May 28; 113(5):1608-15. PubMed ID: 22174188
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-155 inhibition up-regulates LEPR to inhibit osteoclast activation and bone resorption via activation of AMPK in alendronate-treated osteoporotic mice.
    Mao Z, Zhu Y, Hao W, Chu C, Su H.
    IUBMB Life; 2019 Dec 28; 71(12):1916-1928. PubMed ID: 31317664
    [Abstract] [Full Text] [Related]

  • 18. [Osteoclastogenesis and bone resorption].
    Nakamura M, Nakamichi Y, Nakamura H, Udagawa N.
    Nihon Rinsho; 2009 May 28; 67(5):889-96. PubMed ID: 19432105
    [Abstract] [Full Text] [Related]

  • 19. A novel microRNA regulates osteoclast differentiation via targeting protein inhibitor of activated STAT3 (PIAS3).
    Liu T, Qin AP, Liao B, Shao HG, Guo LJ, Xie GQ, Yang L, Jiang TJ.
    Bone; 2014 Oct 28; 67():156-65. PubMed ID: 25019593
    [Abstract] [Full Text] [Related]

  • 20. LncRNA Bmncr alleviates the progression of osteoporosis by inhibiting RANML-induced osteoclast differentiation.
    Chen RS, Zhang XB, Zhu XT, Wang CS.
    Eur Rev Med Pharmacol Sci; 2019 Nov 28; 23(21):9199-9206. PubMed ID: 31773670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.